Detalles de la búsqueda
1.
Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.
Hepatol Res
; 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517681
2.
Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.
Hepatol Res
; 53(9): 815-828, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243512
3.
Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation.
Hepatol Res
; 52(5): 449-461, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113468
4.
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
J Med Virol
; 92(3): 329-338, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31777965
5.
Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis.
Hepatol Res
; 50(11): 1264-1274, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32833292
6.
Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.
Hepatol Res
; 50(12): 1355-1364, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32886950
7.
Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus.
Hepatol Res
; 50(4): 512-523, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31837277
8.
A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing.
Hepatol Res
; 49(9): 1083-1087, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30924272
9.
Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.
Hepatol Res
; 48(3): E372-E378, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28872737
10.
Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-ß injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy.
Hepatol Res
; 48(4): 233-243, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28884930
11.
"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline.
Hepatol Res
; 47(13): 1397-1407, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28239934
12.
Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism.
Hepatol Res
; 46(12): 1234-1246, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26878268
13.
Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices.
J Gastroenterol Hepatol
; 31(11): 1844-1850, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27003222
14.
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
J Med Virol
; 92(8): 1370, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32677098
15.
Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL-28B Gene Allele and Viral Response Trial (AG & RGT).
Hepatol Res
; 45(11): 1091-9, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25580859
16.
Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient.
Hepatol Res
; 44(11): 1130-1141, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24020990
17.
Transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison of the therapeutic efficacies between miriplatin and epirubicin.
Hepatol Res
; 44(11): 1072-80, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23957866
18.
Therapeutic strategy for patients with bleeding rectal varices complicating liver cirrhosis.
Hepatol Res
; 44(11): 1088-94, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24033909
19.
Balloon-occluded retrograde transvenous obliteration using a microballoon catheter for intractable gastric fundal varices.
J Gastroenterol Hepatol
; 29(2): 365-71, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23927078
20.
Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma.
PLoS One
; 19(4): e0298770, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38687817